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An essential gene, designated HKE1/RATI, has been isolated from the yeast Saccharomyces cerevisiae and
characterized. The gene encodes a protein of 116 kDa (p116) and has significant homology to another yeast gene
(XRNI/KEMI) encoding a related protein (p175) with 5'--'3' exonuclease activity as well as activities involving
chromosomal DNA pairing and mechanics. Preliminary analysis of an hkel) mutant reveals a precipitous
decline in the translation of mRNA at the nonpermissive temperature. Sporulation of heterozygous
HKE1/hkel::URA3 diploids reveals that this gene, unlike the highly related XRN1/KEM1 gene, is essential for
cell viability. Overexpression of the homologous gene product, p175, failed to rescue cells lacking a functional
p116. In vitro studies demonstrate that p116 is a protein with 5'- 3' exoribonuclease activity, a major activity
of the related p175. An immunoreactive RNase activity of 116 kDa is abolished with antiserum against p116.
Both the level of this protein and the RNase activity correlate with HKEI gene dosage. The RNase activity
purifies coincidentally with a previously described 116-kDa RNase having 5'- 3' exoribonuclease activity.
We have characterized a temperature-sensitive (ts) mutant
from Saccharomyces cerevisiae that was obtained in a
screen for mutants reduced in the synthesis or binding of a
hybrid protein which competes for the transport of protein
precursors into mitochondria (8). Analysis of this mutant has
led to the characterization of a gene with significant primary
sequence homology to a previously identified gene, XRNJ
(25). XRNJ was also independently identified as KEMI (18),
SEP1 (42), DST2 (10), andRARS (19). The gene is referred to
as XRNI/KEMI in this paper. It encodes a protein of 175
kDa (pl75) which appears to have a multitude of properties,
including involvement in such seemingly diverse functions
as recombination, RNA processing and turnover, microtu-
bule function, karyogamy, and DNA replication (for a sum-
mary, see reference 17). The protein has 5'--3' exoribonu-
clease and DNase activity as well as DNA strand-exchange
activity (10, 25, 42). XRN1IKEM1 gene disruptions have
shown that it is a nonessential gene. The related gene
described in this report was originally designated HKE1 (for
homology to KEMI). Yeast cells lacking functional HKE1
are not viable and cannot be rescued by XRN1/KEMJ, even
in high copy. Analysis of the hkel temperature-sensitive
mutant shows a reduction in the translation of RNA at the
nonpermissive temperature. Furthermore, p116 appears to
have 5'-.3' exoribonuclease activity, as does the related
p175 protein. The nuclear immunolocalization of p116 sug-
gests that its participation in the utilization of mRNA may
occur prior to the translation of mRNA in the cytoplasm.
These phenotypes associated with hkel-l'S may indicate a
role for this protein in the processing and/or trafficking of
nuclear mRNAs.
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In order to understand the activities which operate to
ensure correct processing and transport of RNA, at least two
studies have been initiated with yeasts to take advantage of
the genetic approaches available (3, 16). One of these
studies, designed to uncover RNA trafficking mutants in
Saccharomyces cerevisiae, has yielded a temperature-sensi-
tive mutant that is complemented by a gene identical to
HKE1 (named RATl for RNA trafficking [3]). In this study,
poly(A) RNA localization methods were used to screen for
conditional mutants which appear to be blocked in the
transport of RNA molecules from the nucleus at the restric-
tive temperature. Mutants obtained from these screens (3,
16) appear to be distinct from previously described mutants
that exhibit defects in cytoplasmic mRNA production due to
mRNA splicing (26; for a review, see reference 32).
The studies presented here describe further characteriza-
tion of the HKEJ/RAT1 gene and an hkeltS mutant and show
that pl16 is a protein having 5'-33' exoribonuclease activity,
a major activity of the product of the related XRNJ/KEMI
gene.
MATERIALS AND METHODS
Strains and media. The following yeast strains were used
in this study: SEY2101 (MATa ura3-52 leu2-3,112 suc2-A9
ade2-1 gal2); SEY2102 (AL4Ta ura3-52 leu2-3,112 suc2-A9
his4-519 gal2) (11); GS8-44 (AL4Ta ura3-52 leu2-3,112
suc2-A9 his4-519 gal2 hkel-l''); W303 (ALATa/a ura3-52
leu2-3,112 his3-11,15 trpl-1 ade2-1); YPH500 (MATa
ura3-52 lys2-801 ade2-101 trpl-A63 his3-A200 leu-Al); and
YPH500xmnl (MATa ura3-52 lys2-801 ade2-101 trpl-A63
his3-A200 leu-Al xrn1ABglII::URA3) (25).
Yeast cells were grown in YPD rich medium (1% yeast
extract, 2% peptone, and 2% glucose) or minimal medium
(YNBD [0.67% yeast nitrogen base, 2% glucose] or YNBG
341
342 KENNA ET AL.
[0.67% yeast nitrogen base, 2% glycerol]) supplemented with
appropriate amino acids (34). LSM was used for labeling
experiments (8).
The Escherichia coli strain used for plasmid construction
was MC1066 (F- AlacX74 galU galK rpsL hsdR trpC9830
leuB600 pyrF74::TnS) (29). Bacteria were grown in LB
medium (30). Ampicillin-resistant transformants were se-
lected on LB plates supplemented with 50 ,ug of ampicillin
per ml (30).
Plasmids. The plasmid, pMKHKE1, is the 2,um LEU2
YEp13-based plasmid containing a 5.1-kb insert, including
the entire HKEJIRATI gene, in the BamHI site (see below).
The plasmid pExo2, a YEp24-based plasmid from Larimer
and Stevens (25), contains the XRNI gene. An -8-kb
BamHI-HindIII fragment containing the entire XRNJ gene
was subcloned into YEpl3 to create YEp13XRN1.
Isolation of the temperature-sensitive mutant. The original
temperature-sensitive strain GS8-44 (hkel-1) was identified
as a ts mutant from a screen in yeast cells designed to detect
the mislocalization of a fusion protein in vivo. Earlier studies
had demonstrated that mitochondrial association of an
ATP2-lacZ-encoded hybrid protein to the mitochondrial
inner membrane prevents growth on nonfermentable carbon
sources by an otherwise wild-type host (8, 11). A genetic
screen was devised to select conditional mutants that would
suppress the no-growth phenotype of this hybrid protein yet
still harbor the plasmid, as assayed for by growth on glycerol
and 13-galactosidase activity.
Mutagenesis and genetic analysis. Strains SEY2101 and
SEY2102, both carrying plasmid pCIZ1 (the ATP2-lacZ
plasmid [8]), were mutagenized with either ethyl methane
sulfonate (34) or UV irradiation. For UV mutagenesis, cells
were treated at a cell density of 107/ml in H20 to give
approximately 40% killing. After mutagenesis, cells were
plated onto YNBG plus 5-bromo-4-chloro-3-indolyl-o-D-ga-
lactopyranoside with amino acid supplements and 0.1%
glucose. Colonies growing on these plates after 7 to 10 days
at room temperature which expressed observable 3-galacto-
sidase activity (30) were selected for further study (approx-
imately 10' of survivors). Candidates were subjected to
multiple rounds of screening and were checked for temper-
ature-sensitive growth at 30 and 37°C on both glucose- and
glycerol-containing media. This screening eliminated ap-
proximately 85% of the candidates. To confirm that the
lesion was chromosome linked, the original pC,Z1 was
segregated out by screening for uracil prototrophy and loss
of 0-galactosidase expression. Strains were retransformed
with fresh pCIZ1 and screened for growth on YNBG.
Approximately 60% of the final-found candidates lost the
ability to grow on YNBG upon retransformation with
pCIZ1.
Complementation analysis between SEY2101- and
SEY2102-derived mutants and backcrosses followed stan-
dard genetic protocols (34), as did tetrad analysis and
random spore analysis to select haploids by using the ade2-1
allele. GS8-44 (hkel-l's) was the strain chosen for the genetic
and molecular analyses described in this report. Other
mutants will be described elsewhere.
Cloning the HKEI/RATI gene. Strain GS8-44 (hkel-l's) was
transformed with a yeast Sau3A genomic library inserted
into YEp13. Cells were plated on media selective for trans-
formants at room temperature for 1 day before shifting to
37°C. After 2 days at 37°C, fast-growing colonies were
isolated and rescreened for their ability to complement
hkel-1. Four independent plasmids were identified from over
19,000 Leu+ transformants. The insert DNA from each of
the plasmids shared a common region of 4.1 kb which
contained the full-length gene.
Complementation by HKEI on a centromere plasmid. A
5.1-kb fragment bearing the HKEI gene and 5' and 3'
flanking DNA was amplified by polymerase chain reaction
(PCR) with primers flanking the BamHI site of YEp13 in the
plasmid pMKHKE1. This insert was then cloned into the
BamHI site of pRS316, a CEN6 plasmid (35), and trans-
formed into GS8-44 and its derivatives. The ability of the
gene to complement the ts mutation was analyzed by grow-
ing cells containing this plasmid at 23 and 37°C.
Integrative mapping. Integrative mapping was used to
demonstrate that the gene cloned by complementation of the
ts mutant mapped to the same genetic location as the allele
responsible for the temperature-sensitive phenotype. A
2.3-kb SalI fragment from YEp44-7, one of the four comple-
menting plasmids, was subcloned into the yeast integrating
vector YIp5. Integration of this plasmid was directed to the
HKEJ region of the genome by transforming wild-type strain
SEY2101 with KpnI-linearized DNA. Correct integration at
the HKEI locus was confirmed by Southern analysis of
genomic DNA prepared from the transformant. This trans-
formed strain was then mated to GS8-44 containing the
temperature-sensitive hkel-1 mutation. Diploids were sporu-
lated, and the Ura+ phenotype was meiotically mapped in
relation to the hkel-1 allele. Tetrad analysis confirmed that
the cloned sequence represents the wild-type gene of the
mutant allele in the hkel-1 strain.
Yeast transformation. Yeast cells were made competent
for transformation with lithium acetate (14).
Nucleic acid methods. Standard procedures were used for
restriction digestions and plasmid constructions. Restriction
enzymes and T4 DNA ligase were used according to the
instructions of the supplier. DNA fragments were purified
from agarose, and DNA transformation in E. coli was
performed as described by Maniatis et al. (27).
The HKE1 gene was sequenced as either a single-stranded
or double-stranded template. Dideoxy sequencing of DNA
was accomplished by using a kit from New England Biolabs,
single-stranded DNA cloning vectors, and universal primers.
Double-stranded plasmid DNA was sequenced with either
Sequenase (United States Biochemical Corp.) or a double-
stranded DNA cycling sequencing system (Bethesda Re-
search Laboratories) using Taq DNA polymerase. The se-
quencing vector Bluescript (Stratagene) was used to
subclone certain restriction fragments of HKE1, and se-
quence was obtained from universal sequencing primers.
Oligonucleotides were synthesized and used as primers to
complete some regions. DNA data analysis was performed
by using the MacVector (IBI) program. Protein sequence
alignment with sequences in the NBRF and GenBank data
bases was performed by using the TFASTA program within
the University of Wisconsin Genetics Computer Group
program (7). The DNA sequence and protein sequence
alignment were identical to those previously presented (3).
Disruption of HKEI. A 5.1-kb fragment bearing the HKEI
gene and 5' and 3' flanking DNA was amplified by PCR with
primers flanking the BamHI site of YEpl3, in the plasmid
pMKHKE1. Additional BamHI sites were created de novo
by the PCR method and used for convenient subcloning of
the entire genomic fragment containing HKE1 as a single
BamHI fragment. The 5.1-kb BamHI fragment was cloned
into the BglII site in the polylinker reglon of pSP71
(Promega) to create pHKE71. pHKE71 was digested with
SalI-SacII to remove a 430-bp internal fragment near the 5'
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FIG. 1. HKEI/RATI is an essential gene. DNA constructions to
disrupt HKEIIRATI. A 3.8-kb that consists of the yeast URA3 gene
flanked by direct repeats of Salmonella hisG DNA (2) was used to
disrupt HKEI/RATI by insertion into the SalI-SacII sites within the
5' region of the gene (restriction sites used were as follows: B/Bg,
BamHI-BglII; H, HindIII; Rl, EcoRI; S, Sall; Ssl, Sacl; Ss2,
SacII; and X, XbaI) as described in detail in Materials and Methods.
A linear fragment containing this construct was then used to
transform the diploid strain W303. Tetrad analysis of the HKEI/
hkel::URA3 diploid revealed a segregation pattern of 2 viable
spores:2 inviable spores. Treatment of Ura+ transformants with
5-FOA selects for cells that have excised the URA3 gene because of
recombination between the direct repeats of the hisG gene and are
therefore ura3 mutants but maintain the hkel::hisG gene disruption.
Tetrad analysis of this diploid also gave rise to 2 live:2 dead spores.
end of HKEI. The linear -7-kb fragment was isolated and
used as the recipient for the input DNA described below.
A 3.8-kb fragment that consists of the yeast URA3 gene
flanked by direct repeats of Salmonella hisG DNA (2) was
subcloned into the polylinker region of Bluescript vector
(Stratagene). A Sall-SacII fragment was isolated from this
construct and subcloned into the SalI-SacII site within the
HKEI gene in pHKE71. The resulting plasmid, pHKE71::
hisGURA43, was digested with XhoI and AatII to release an
-8-kb fragment useful for integrative transformation into the
diploid yeast strain W303 (31). Ura+ transformants were
selected and confirmed by Southern analysis. Individual
transformants were subsequently used to detect excision
events that would lead to a Ura- phenotype and were
selected for on 5-fluoro-orotic acid (5-FOA) (5). Figure 1
depicts the disrupted HKE1 gene.
Antibody production. An in-frame gene fusion between the
E. coli trpE gene and HKEI/RATI was made by ligating an
internal HindIII 706-bp fragment into the HindIII site of
pATH1l (20). The resulting plasmid coded for a fusion
protein consisting of amino acids 168 to 403 from p116 fused
to the first 324 amino acids of the trpE protein, creating a
hybrid protein of approximately 66 kDa. Rabbit polyclonal
antibodies were generated to the gel-purified trpE fusion
protein. For immunofluorescence and Western immunoblot
applications, crude sera were then immunopurified as fol-
lows: fusion protein was obtained from E. coli extracts,
electrophoresed by preparative sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis, and transferred
to nitrocellulose. The nitrocellulose was stained by Ponceau
S to visualize protein, and the strip containing the fusion
protein was excised. Crude antisera to p116 were incubated
with the strip following standard Western blot procedures.
The bound antibodies were eluted from the nitrocellulose by
treatment with 0.2 M glycine-1 mM EGTA [ethylene glycol-
bis(,-aminoethyl ether)-N,N,N',N'-tetraacetic acid] (pH
2.7) and neutralized with 3 N NaOH. Immunopurified anti-
sera was tested by Western analysis for its immunoreactivity
to p116.
Indirect immunofluorescence. Anti-trpE::p116 antibodies
were used for immunofluorescence as described by Adams
and Pringle (1). To visualize nuclear DNA, cells were stained
with 0.5 ,ug of 4,6-diamino-2-phenylindole (DAPI) per ml.
Treated cells were mounted on glass slides in 1 mg of
p-phenylenediamine per ml in 90% glycerol. Cells were
examined and photographed by using fluorescence micros-
copy with a Nikon Optiphot Microscope fitted with UV,
fluorescein isothiocyanate, and rhodamine filters and
Nomarski (DIC) optics. Kodak T-Max 400 35-mm film was
used for all photography. NOPJ antibody was a gift from
John Aris (4).
Protein synthesis. Cells were grown overnight to log phase
at 23°C in YPD. Cells were harvested, washed twice with
water, resuspended to 107 cells per ml in low-sulfate medium
(LSM [see above]), and incubated for 30 min at 23°C prior to
the zero-time labeling point. At time zero, cells were split
and half of each culture was shifted to 37°C. For each
labeling point, 1 ml of culture was removed and labeled for 5
min at 23°C with 5 ,uCi of Na235SO4. Labeling was termi-
nated by addition of 1 ml of 5% trichloroacetic acid plus 1%
Casamino Acids. Samples were collected and counted by
using GFA glass filters.
Protein manipulations. Yeast whole cell extracts were
prepared by glass bead lysis in radioimmunoprecipitation
assay buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris-HCl [pH 8.0]) plus
protease inhibitors (13). Total and insoluble E. coli proteins
were prepared by the method of Koerner et al. (20). Proteins
from RNase-containing fractions were precipitated with tri-
chloroacetic acid to 5%. Proteins were separated electro-
phoretically on 7.5 or 10% gels by the method of Laemmli
(23) and were transferred to nitrocellulose by using a Bio-
Rad semidry transfer apparatus (13). For immunoblotting of
hydroxylapatite column fractions, nitrocellulose membranes
were blocked for 1 h in 5% instant milk in TTBS (20mM Tris
[pH 7.5], 500 mM NaCl, 0.05% Tween 20) and washed in
TIBS. Washed blots were incubated 1 to 2 h with the
appropriately diluted antiserum. Blots were then washed
again and reacted with an anti-rabbit secondary antiserum
(horseradish peroxidase conjugated), and immunoreactive
bands were detected by enhanced chemiluminescence with a
kit from Amersham. Immunoblotting of heparin-agarose
column fractions was carried out with crude p116 antisera as
described by Larimer and Stevens (25) by using "2I-protein
A (ICN).
Exoribonuclease analysis. Enzymatic assay of exoribonu-
clease activity with [3H]poly(A) as a substrate was carried
out as described previously (36, 41) and a unit of activity,
previously defined (41), is the amount needed to release 5
nmol of l H]AMP from 150 nmol of [3H]poly(A) per 30 min
at 37°C. Hydroxylapatite column fractions were also assayed
with the addition of 20 mM EDTA to the reaction mixtures,
VOL. 13, 1993
344 KENNA ET AL.
and the values obtained were subtracted from the plus Mg2+
values. The Mg2 -independent activity was less than 10% of
the Mg2+-dependent activity in all cases. Cells were grown
in 1 liter of minimal medium to an A650 of 1.7 to 1.9 and
harvested. Crude extracts were prepared from the yeast
parental strain grown with or without the 2pm plasmid
harboringHKEI (PMKHKE1) by the procedure described in
Fig. 1 of Larimer and Stevens (25). The parental strain and
the hkel'S mutant were grown similarly. Extracts (1 ml) were
resolved by hydroxylapatite (Bio-Rad) chromatography
(2.7-ml columns) exactly as previously described (25). A
40-ml linear gradient (50 to 500 mM potassium phosphate
buffer [pH 7.6]) was used, 1-ml fractions were collected, 15
pl of every other fraction was assayed, and the results were
plotted graphically as units of activity versus fraction num-
ber (see Fig. 5). The heparin-agarose chromatography was
carried out as described in the legend to Fig. 6.
RESULTS
Cloning and sequence analysis of the HKEI gene. A genetic
screen to select temperature-sensitive (ts) mutants that ex-
hibited altered transport of mitochondrial protein precursors
yielded several mutants falling into different complementa-
tion groups, that were somehow defective in mitochondrial
translocation. These studies will be presented elsewhere. In
the course of this study, however, we arrived at one mutant
in which the temperature sensitivity phenotype segregated
independently of the mitochondrial defect. We also cloned
this temperature-sensitive gene and showed it was an essen-
tial gene whose preliminary sequence analysis provoked an
interest in pursuing further characterization (see below and
Discussion). In this report, we describe the molecular char-
acterization of this gene and the biochemical analysis of its
gene product.
To further characterize the temperature-sensitive mutant,
the recessive ts allele was genetically complemented and
shown to be the allele responsible for the temperature-
sensitive growth by integrative mapping (see Materiats and
Methods). The complementing fragment was sequenced and
contained an open reading frame of 1,007 codons (3,021 bp)
encoding a protein of approximately 116 kDa (calculated
molecular weight, 116,773).
The oldest complete sequence within the data base that
revealed a significant homology with our open reading frame
was the sequence for the yeast gene KEMI (18). In at least
four other independent studies, the KEM1 gene was identi-
fied from different activities and namedXRN1, SEP1, RAR5,
and DST2 (for a summary, see reference 17). For the
purposes of this report, we will refer to the gene as XRN1I
KEM1, and the protein it encodes (175 kDa) will be referred
to as p175.
Because of the high homology of the complementing gene
with XRNI/KEMI and the potential for related function, it
was originally named HKEJ because of its homology to the
karyogamy enhancing gene, KEMI. (Alignment of the HKE1
amino acid sequence with that for KEMI revealed several
regions of significant stretches of homology, including 37%
identity over 414 amino acid residues [3; data not shown].)
Concurrent with our studies, although not yet present in the
data base, were the sequence and molecular characterization
of another gene (RATI), which we now know to be identical
to HKEJ (3). Since our sequence was the same, it is not
presented here. In order to be consistent with the literature,
we will use HKEI/RATI when referring to the gene name
and p116 when referring to the protein.
1 2 3 1 2 3
WT
mutant
mutant + pl 16
mutant + p175
230C 370C
FIG. 2. XRNJ/KEMl fails to rescue the temperature sensitivity
phenotype of hkel-1. hkel-I is temperature sensitive for growth
which is not reversed by the presence of the XRN1 gene on a 2,m
plasmid (YEpl3XRN1). Shown are duplicate plates (23 or 37°C) of
serial dilutions (columns: 1, -103 cells; 2, -102 cells; 3, -101 cells)
of the wild-type (WT) or mutant strains indicated as mutant (hkel's),
mutant + p116 (hkel's transformed with HKEl/RATl on a 2,um
plasmid, pMKHKEl), or mutant + p175 (XRNIKEM1 on a 2tm
plasmid, pExo2).
HKEI/RA4T1 is an essential gene that cannot be rescued by
multicopy XRNI/KEMI. A URA3 gene flanked by hisG
repeats (see Materials and Methods) (Fig. 1) was inserted
into HKE1 and integrated into the genome to generate a
heterozygous HKElIhkel::hisG diploid. The correct physi-
cal insertion of the integration was confirmed by Southern
analysis (data not shown). Sporulation and tetrad analysis of
this diploid revealed that spores harboring the hkel::hisG
disruption were not viable. Microscopic examination of the
disruptive spores revealed an early block in cell division.
The spores either did not germinate or arrested growth after
a single division. These data suggest an important role for
the HKEJIRATJ gene product in cell growth. A diploid strain
bearing the disrupted gene and a wild-type copy of the gene
on a UR43 plasmid was sporulated, and tetrads were dis-
sected. Spores were allowed to germinate on rich medium
and were later replicated to plates containing 5-FOA (5). All
the cells that carry the hisG gene insertion (confirmed by
PCR strategies) could not grow on 5-FOA, demonstrating
that the disrupted strain requires the plasmid-borne copy of
the gene for mitotic growth (data not shown). This result
confirms that of Amberg et al. (3) for the disruption of RATIJ.
To confirm the independence of the cellular activities
ascribed to the HKEJ/RATJ and homologous XRNI/KEM1
gene products, the hkel-I mutant was transformed with
XRNJ/KEMI on a multicopy plasmid (pExo2) to determine
if increased levels of p175 could rescue cells at the nonper-
missive temperature. The transformed cells were compared
with the hkel-l's mutant cells rescued with the HKEJ/RATJ
plasmid. As shown in Fig. 2, the thermosensitive growth of
the hkel-l' mutant was not rescued by XRNJIKEMJ under
conditions in which HKEJ/RATI rescued growth at 37°C.
Additionally, the XRNI/KEMJ gene on a multicopy plasmid
(pExo2) did not rescue the lethality of an hkel/ratl ::URA3
disruption strain upon sporulation and tetrad analysis. The
meiotic products from a disrupted diploid strain bearing
XRN1IKEMI oii a multicopy plasmid segregated as 2 via-
ble:2 inviable spores (not shown). Parallel, control experi-
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FIG. 3. Intracellular localization of p116. Polyclonal antibodies
were generated to a trpE fusion protein made from amino acids 168
to 403 of p116. Crude sera were then immunopurified against the
fusion protein obtained from E. coli extracts. Yeast cells bearing the
hkel/ratl::URA3 disruption and HKE1/RATJ on a high-copy-num-
ber vector (pMKHKEl) were fixed and prepared for immunofluo-
rescence with trpE::pll6 antibody as described in Materials and
Methods. (A) Cell field as viewed by DIC optics; (B) the same cells
stained with DAPI to visualize the nuclei; (C) fluorescence of the
trpE::pll6 antibody, indicating a nuclear location for this protein in
some of the cells.
ments were performed with pExo2 in the disruption mutant
YPH500km1 to ensure that this plasmid can rescue the slow
growth phenotype of an XRNI/KEMJ disruption mutant
(25).
Antibody localization. Indirect immunofluorescence of
wild-type yeast cells bearing HKEI/RATl on a 2p,m plasmid
(pMKHKE1) using the anti-trpE::pll6 antisera revealed a
nuclear location for p116 in approximately 30 to 40% of the
cells in a given field. The staining is distributed over the
nucleus in the same space defined by DAPI detection of
nuclear DNA (Fig. 3). Not shown is a control experiment
using NOP1 antibodies. NOP1 is a nucleolar protein (4), and
staining from this antibody was evident in the nuclei of all
cells. This uniform nuclear staining by NOP1 indicates that
the lower percentage of nuclear staining found with the
anti-p116 antibodies was not likely due to artifactual effects
from fixation or spheroplasting. It is possible that the nuclear
localization in only some cells reflects a cell cycle-specific
regulation of the localization of p116. However, because of
the relatively low abundance of this protein in wild-type
cells, antibody localization requires the expression of p116
from a multicopy plasmid. This may affect the normal
subcellular localization of a protein.
Translation defect in HKE1'3. In the study by Amberg et al.
(3), RATl was identified from a screen designed to isolate
temperature-sensitive mutants involved in the trafficking of
mRNA from the nucleus. In situ localization of mRNA in
this mutant reveals that it is not as efficiently released from
the nucleus to the cytoplasm at the nonpermissive tempera-
ture. Mutant cells held at 37°C exhibit a marked nuclear
staining of mRNA and loss of a cytoplasmic poly(A) signal
compared with those of cells at 23°C or of the wild type at
either temperature. In a similar study by Kadowaki et al. (16)
a mutant (mtrl) that shows a similar mRNA nuclear reten-
tion phenotype is described. These authors additionally
demonstrate that protein synthesis is decreased in this
mutant while mRNA levels remain constant. To determine if
the hkel-l's mutant exhibited a similar phenotype, we exam-
ined protein synthesis in this mutant.
Wild-type and hkel-ls cells were labeled with Na235SO4 at
the permissive and nonpermissive temperatures, and the
abilities of the cells to incorporate amino acids were assayed
(Materials and Methods). Protein synthesis in the hkel-1
temperature-sensitive mutant was significantly lower than
that of wild-type cells following a shift to 37°C. After shifting
to the nonpermissive temperature, protein synthesis in the
mutant begins to be reduced to levels less than 10% of that of
wild type (Fig. 4B). The decrease in protein synthesis could
reflect some posttranscriptional event that blocks the acces-
sibility of RNA to the translation apparatus.
Evidence that the HKEI/RATI gene encodes a protein with
exonuclease (RNase) activity. The homologous p175 protein
encoded by the XRNJIKEMI gene has been found to have
5'--3' exoribonuclease activity and 5'-)3' DNase activity
and to catalyze DNA strand exchange (for a review, see
reference 17). It was first identified in studies of 5'--*3'
exoribonuclease activities in S. cerevisiae over 10 years ago
(36, 41). Yeast exoribonuclease activities elute from hydrox-
ylapatite columns in two discrete peaks (36) and are the
predominant activities that hydrolyze poly(A) at pH 9.4 and
require Mg2+. These exoribonuclease activities account for
>80% of the Mg2+-dependent RNase activity of cytoplasmic
and ribosome fractions of yeast cells (38). Earlier studies
demonstrated that the exonuclease peak eluting from hy-
droxylapatite at higher salt concentrations was due to p175,
the XRNI/KEM1 gene product (25, 36). The first RNase
peak, eluting at a lower salt concentration, has not been as
extensively characterized, but it has been further purified
(37) and found to degrade 5' terminally labeled rRNA and
[5,_32p, 3H](pA)4 in the same manner as described for p175
(36, 38) (see Fig. 7). It is referred to as exo-2 below. To
determine if the exoribonuclease activity of the lower-salt
hydroxylapatite column peak was due in part to the highly
conserved HKEJIRATJ gene product, we prepared protein
extracts for hydroxylapatite column chromatography from a
yeast strain harboring HKE1/RATl on a multicopy plasmid
and from the same strain without the plasmid. Quantitation
of Mg2 -requiring poly(A)-hydrolyzing activities of fractions
eluted from the hydroxylapatite columns revealed a four- to
fivefold increase in the level of nuclease activity cofraction-
ating with the peak eluting at lower salt concentrations in
yeast cells bearing multiple copies ofHKEJIRA T1 (Fig. SA).
Because of the high level of this peak, p175 activity is found
only as a shoulder of activity. The overproduced HKEI/
RATI activity eluted in the same location as the peak of
activity shown previously to remain in yeast cells harboring
VOL. 13, 1993
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FIG. 4. Protein synthesis in hkel-l's. (A) Log-phase cells grown
at 23°C were shifted into fresh medium at the indicated tempera-
tures. Aliquots were taken at the times indicated, and the optical
density (OD) at 600 nm was determined. Open symbols represent
cultures growing at 23°C and filled symbols represent cultures
growing at 37°C. (B) Protein synthesis was assayed by incorporation
of Na235SO4 as described in Materials and Methods. At the times
indicated, aliquots containing the same numbers of cells were
removed from the culture flask and labeled for 5 min by the addition
of 5 pCi of Na235SO4. Samples were treated as described and plotted
as counts per minute versus time. Open symbols represent cultures
growing at 23°C in LSM and filled symbols represent cultures
growing at 37°C in LSM. WT, wild type.
a disruption of the p175-encoding gene (25). The increase in
RNase activity is comparable to that observed for overpro-
duction of p175 under identical conditions in earlier studies
(25). The hkel-lts mutant and parental strain were also
grown at 23°C, and extracts were examined in the same
manner by hydroxylapatite chromatography. The extract of
the parental strain showed results similar to those of Fig. SA;
however, the poly(A)-hydrolyzing peak eluting at lower salt
concentrations was reduced to about 30% of the parental
level in the hkeltS mutant (data not shown). The hkel-l's
strain also grows more slowly, even at 23°C (Fig. 4A).
The increased level of RNase activity observed in Fig. SA
was consistent with an increased synthesis of the HKEI/
RATI gene product from the multicopy HKEI/RATJ plas-
mid. However, the increase could also result from regulation
of the synthesis or activity of the RNase by the HKEI/RATl
gene. To eliminate this possibility, we used p116 antibody to
show that it recognized a protein of the expected size of the
HKEJIRAT1 gene product (116 kDa), that this protein was
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FIG. 5. (A) Separation of exoribonuclease activities from the
p116 overproducing strain. Crude extracts were prepared from the
yeast parental strain grown with or without pMKHKE1 (2,um) and
chromatographed on a hydroxylapatite column, and fractions were
assayed for exoribonuclease activity (see Materials and Methods).
The values obtained were plotted as units of RNase activity versus
fraction number. The peak of exoribonuclease activity at higher salt
concentrations in fraction 24 of the wild-type extract is due to p175
(21). This peak of activity was only noted as a shoulder of the major
low-salt peak in the HKEJ/RATI overproducing strain. (B) Western
blot of p116 in exonuclease-containing fractions. Immunopurified
rabbit antibody to a TrpE::pll6 fusion protein (see Materials and
Methods) was used to probe a Western blot containing hydroxylap-
atite column fractions (Fig. 5A) with increased 5'--3' exoribonu-
clease activity as well as crude extracts. Lanes: extract, equal
protein amounts of crude extracts from the wild-type parental strain
(WT) or WT + pMKHKE1; 14, 16, and 18, equal loadings of total
protein associated with the exoribonuclease peak (fractions 14, 16,
and 18, respectively) of WT or WT + pMKHKE1.
reacted with the RNase activity in these fractions. Immu-
noaffinity-purified antiserum to p116 was prepared (see Ma-
terials and Methods) and used to probe the crude extracts
and the partially purified hydroxylapatite peak fractions (14,
16, and 18) of RNase activity found in Fig. 5A. These studies
showed that a protein of approximately 116 kDa was found
in the fractions and recognized by the antiserum against p116
(Fig. 5B). The level of this protein was considerably in-
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TABLE 1. Immunodepletion of RNase activity by
anti-p116 antibodiesa
Enzyme fraction % Activity
and serum (,ul) remaining
16 (WT)
None ........................................... 100
Preimmune (1) ....................... .................... 97
Preinmune (2.5) ........................................... 95
Immune (1) ................. .......................... 12
Immune (2.5) ..................... ...................... 10
16 (WT + pMKHKEl)
None ........................................... 100
Preimmune (1)........................................... 104
Preimmune (2.5) ........................................... 107
Immune (1) ................. .......................... 19
Immune (2.5) ..................... ...................... 10
Heparin-agarose-purified exo-2
None ........................................... 100
Preimmune (1) ....................... .................... 100
Preimmune (2.5) ........................................... 93
Immune (1) ................. .......................... 17
Immune (2.5) ........................................... 7
a Aliquots of the hydroxylapatite column fraction 16 of the wild-type
extract (3 pg) and the wild-type plus pMKHKE1 extract (3.5 pg) (Fig. 5A, WT
and WT + pMKHKEl, respectively) and 0.9 ig of a heparin-agarose-purified
exo-2 (36) were mixed with antiserum as shown above in reaction mixtures (60
pl) containing 16 mg of albumin per ml, 1.6% Nonidet P-40, 50 mM NaCI, and
3.3 mM sodium phosphate buffer (pH 7.2). After 4 h at 4'C, protein A-agarose
(Pierce) (30 pL1 of a 50% suspension) was added, and the suspensions were
mixed for 2.5 h at 4°C. Aliquots of the supematant solutions following
centrifugation were assayed as described in Materials and Methods, and the
percent activity remaining in the supematant is shown. The amount of crude
rabbit antisera used is indicated.
harboring the multicopy plasmid pMKHKE1. The size of
this protein correlated well with the estimated size (116 kDa)
from DNA sequence analysis ofHKEI/RATI. The protein is
barely detected in whole cell extracts at a protein level at
which the overproduced protein is readily apparent [Fig. 5B,
WT versus WT + (pMKHKE1)]. The activity increase
measured (Fig. 5A) may represent a low estimate of the
actual increase in vivo.
Immunodepletion of RNase activity was tested by the
addition of the p116 antiserum to the peak hydroxylapatite
fractions of Fig. 5A, as well as to a preparation of exo-2
purified from the YPH50QnJl yeast strain as described by
Stevens (37). Table 1 shows the results of the immunopre-
cipitation of RNase activity by the trpE::pll6 fusion protein
antibody. Approximately 90% of the RNase activity was
depleted from all the RNase-containing fractions upon incu-
bation with the immune antiserum but not upon incubation
with the preimmune serum.
Further purification by heparin-agarose column chroma-
tography and Western immunoblot analysis of the overex-
pressed (HKElIRATl plasmid-dependent) RNase activity
was done so that a coincidental purification of the activity
with that of the previously described exo-2 (36, 37) could be
demonstrated. These data are presented in Fig. 6. The
overexpressed poly(A)-hydrolyzing activity of the hydroxy-
lapatite column fractions obtained by chromatography of
crude extracts (Fig. SA) purifies similarly on a heparin-
agarose column to the exo-2 activity purified from a high-salt
ribosome wash from yeast cells containing a disruption of
XRNJ (37). The heparin-agarose chromatography results in
an 8- to 10-fold purification of the RNase activity. All the
overexpressed activity eluted in the peak shown. Figure 6B
shows a Western blot of the peak fractions of each column.
A protein band of approximately 116 kDa is immunoreactive
in each case and its elution profile parallels that of the
activity. Although a difference in specific activity, i.e.,
RNase activity per immunoreactive protein, between the
overexpressed and exo-2 fractions (approximately 1.5- to
2-fold; compare overexpressed fraction 37 with exo-2 frac-
tion 32 [Fig. 6B]) is apparent, quantitation of the actual
amounts of protein loaded and present in the bands (e.g., by
staining) was not possible because of the very low levels of
protein (less than 20 ,ug/ml in the case of the exo-2 fractions).
It is possible that the overexpressed protein differs in a
structural modification(s) affecting RNase activity or immu-
noreactivity.
The poly(A) hydrolytic activity from both columns was
found to be Mg2e dependent, with 98% of the product being
5'-AMP (data not shown). Most of the studies of the mode of
hydrolysis by exo-2, purified in the same manner as de-
scribed in the legend to Fig. 6, have been done with
[3H]poly(A) as the substrate (38). These studies also showed
that about 98% of the hydrolysis product is 5'-AMP, with the
remaining 2% being short adenylate oligonucleotides (2 to 4
nucleotides long). These are probably derived from the
termini of the chains, since exoribonucleases often fail to
hydrolyze the chain completely (36). With [5_-32P,
3H]poly(A) as a substrate, the only 32P-labeled product is
5'-AMP. Poly(A) lacking a 5'-phosphate end group is hydro-
lyzed by exo-2 at 25% of the rate of poly(A) containing a
terminal phosphate. Similar findings have been found for
p175 (41). The hydrolysis of RNA substrates has not yet
been studied in detail, but Fig. 7 shows an analysis of the
type of exoribonuclease activity of purified exo-2 fractions,
prepared in the same manner as those shown in Fig. 6, using
yeast [5'-32P, 3H]rRNA (25S) as a substrate at 0'C. Label
release upon incubation with the RNase was measured. The
results show that the 5,_32p label is released considerably
faster than the 3H label, showing that a 5'->3' mode of
hydrolysis is a predominant one. The enzyme fractions do
not contain phosphatase activity since no conversion of
5'-AMP to adenosine or [5'-32P]poly(A) to 32Pi was found.
Further analysis of the substrate and reaction specificity of
exo-2 is in progress.
DISCUSSION
In the present study we have characterized a conditional
yeast mutant that is defective in the nucleolytic hydrolysis of
RNA. The essential HKEJ/RATI gene uncovered by this
mutation encodes a protein with significant homology to
another yeast protein (p175) that exhibits a variety of bio-
chemical activities, from strand exchange to exoribonu-
clease activity (17). In addition to the mRNA trafficking data
pre"iously published for RATl (3), we show in the present
sty. J that the HKEI/RATJ gene product exhibits a 5'--3'
exoribonuclease activity like that previously demonstrated
for the related p175.
p175 was purified to homogeneity based on its 5'--3'
exoribonuclease activity (36, 41), and the gene encoding it
was designated in subsequent studies as XRNJ (exoribonu-
clease 1 [25]). These earlier results on the analysis of poly(A)
hydrolytic activity in cells lacking the active XRNJ gene
suggested that a second 5'--3' exoribonuclease which could
partially compensate for the loss of p175 in xrnl disruption
mutants existed (25). We have provided evidence that this
VOL. 13, 1993










FIG. 7. Hydrolysis of [5'-32P, 3H]rRNA by exo-2. [5 _32p, 3H]
rRNA (25S) was prepared as described by Stevens and Maupin (40).
The RNA (1.3 nmol) was incubated for the times shown at 0°C with
50 U of exo-2 (purified as described elsewhere [37]) in reaction
mixtures (50 ,ul) containing Tris-HCl buffer (pH 8.0) (25 mM),
NH4Cl (50 mM), MgCl2 (3 mM), dithiothreitol (0.5 mM), and 30 p,g
of albumin. Assay of acid-soluble radioactivity was done as previ-
ously described (41). Control values for reaction mixtures lacking
enzyme were subtracted.
___wi__s_------ 7- r -r--- -t --r----' second enzyme is encoded by the essential gene HKEJ/
0 10 20 30 40 RAT1.
FRACTION NO. The gene for p175 was also cloned and sequenced in four
other laboratories. By using an assay that detects the trans-
fer of one strand of a DNA molecule to a complementary
single-stranded partner (21), a gene for a strand-exchange
W T + pM K H KE1 E x o - 2 protein, designated SEPI, was characterized (42) and was
-I independently confirmed by others and designated DST2 (9,
23 26 29 32 35 37 26 28 30 32 34 36 10). SEPI was also shown to contain a 5'--3' exonuclease
0.6 1.7 3.4 3.4 2.3 1,3 0.3 0.8 1.7 2.2 1.8 0.8 activity for the hydrolysis of both single- and double-
stranded DNA (15). It is this latter activity that is likely
responsible for synapsis and the observed 5'-*3' polarity of
the strand-exchange reaction. However, the mechanistic
u* details of this activity are not resolved at present (17).
Kolodner et al. (21) have data suggesting that p175 plays an
important role in meiotic recombination. Finally, two other
studies utilizing in vivo mutant screens that report either the
fidelity of nuclear fusion (18) or the mitotic stability of
minichromosomes containing altered origins (19) have
yielded the same gene, designatedKEMI and RAR5, respec-
tively.
What do these seemingly different activities have to do
with one another? Certainly, the same exonuclease could beHeparin-agarose chromatography of the overex- involved in a number of different hydrolytic reactions and
activity and exo-2.Hydroxylapatite chromatography each reaction could affect distinct processes. Loss of thethe yeast strain (0.4 g) containing the high-copy-
l/RATI plasmid was carried out as described in exonuclease could result in a confusing array of phenotypes.
Methods by using a 9-ml column and an 80-ml gradient Events in which 5'-*3' exoribonucleases may be involved
phosphate buffer as described previously (36). Assay have been described previously (41) and are discussed again
iowed an elution profile similar to that of Fig. SA. below. Recent studies with p175 mutants show that mRNA
o 17, containing 4 x 103U of RNase activity, were turnover may be affected, resulting in differences in cellular
ited with an equal volume of 20 mM Tris-HCl buffer mRNA and protein levels (24). Vreken and Raue also have
glycerol, and applied to a 4-ml column of heparin- recently presented results suggesting the involvement of
a) prewashed with the same buffer containing 100 mM such an exonuclease in mRNA turnover (43). A role for an
he column was then washed with 8 ml of the same
ted with a 40-ml linear gradient of 100 to 600 mM exonuclease in such a process could affect many other
In 1Im;111ltPr frnrtinne xw .-r..nih4tfi-dsnt1 nliniint activities in the cell.kI'n4)2Z5k4. une-mllninlter i ac o s weoreconcult;lcu, anlu kiiquoLs
were assayed by using [3H]poly(A) as a substrate as described in
Materials and Methods. Approximately 5.5 x 103 U of RNase
activity was recovered. For the exo-2 chromatography, exo-2 was
purified as described by Stevens (37) from 5 g of the YPH5Oxrml
yeast strain through the hydroxylapatite chromatography step.
Hydroxylapatite fractions (fractions 13 to 17) were combined, and
12 x 103 U of RNase activity was chromatographed on heparin-
agarose as described above. Aliquots of the fractions were assayed,
and 9.8 x 103 U of activity was recovered. The elution profile,
normalized to 50 U of activity, is plotted for each column. (Both
protein and RNase activity elute from the current heparin-agarose
columns at a higher salt concentration than previously described [37],
apparently because of a difference in the heparin-agarose.) (B) Western
blotting was carried out as described in Materials and Methods, by
using 500 p.l of the designated overexpressed RNase fractions and 200
,ul of the exo-2 fractions. The units of RNase activity that were
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HKE1IRATI exoribonuclease activity and related pheno-
types. An array of phenotypes is also found with the condi-
tional HKEJIRAT1 gene mutants. In vivo labeling studies to
characterize the consequences of conditional defects asso-
ciated with the loss of HKEJ/RATl activity reveal a post-
transcriptional block in RNA utilization. Translation of
mRNA is severely reduced ,at the restrictive temperature.
This result might be expected in light of the findings of
Amberg et al. for RAT1 (3). In situ localization of mRNA in
this mutant reveals that it is not as efficiently released from
the nucleus to the cytoplasm at the nonpermissive tempera-
ture. Mutant cells held at 37°C exhibit a marked nuclear
staining of mRNA and loss of a cytoplasmic poly(A) signal
compared with that of cells at 23°C or that of wild-type cells
at either temperature. This phenotype for defects in hkell
ratl mutants could be due to the failure of nuclear mRNA to
efficiently clear the transcriptional process or the nucleocy-
toplasmic translocation apparatus (for a review, see refer-
ence 28). HKEJ/RAT1 was also cloned independently in two
other laboratories (12, 33), where it was uncovered as a
temperature-sensitive suppressor of a tRNA promoter mu-
tation (12) and as a gene whose overexpression would
restore wild-type growth to yeasts bearing an overproduced
amount of a mutated form of the transcription factor TFIID
(33). These data also suggest that p116 may be involved in
transcriptional processes and that the observed transport
defects may be secondary effects due to the lack of produc-
tion of components essential to RNA processing and traf-
ficking.
As far as transcriptional involvement of p116 is con-
cerned, the spectrum of nuclease and strand-exchange ac-
tivities of the related XRNJIKEM1 protein might suggest a
similar potential role for the HKEJIRATl gene product in
transcript displacement from its DNA template (for addi-
tional discussion, see reference 17). However, factors such
as these would be associated with RNA polymerase II, and
thus such a role for p116 seems unlikely, since p116 does not
appear to be a very abundant protein (as revealed by
Western analysis of protein levels and Northern [RNA]
analysis of message levels) relative to polymerase II. Possi-
ble involvement of a 5'- '3' exonuclease in transcription
termination has been suggested by Connelly and Manley (6).
If the exonuclease were not actually involved in the termi-
nation event, it could affect the transcription processing
pathway of mRNA by removing the 3'-terminal fragments
resulting from transcript cleavage for polyadenylation.
Rather than a transcription related function, p116 could be
involved in RNA processing events within the nucleus.
Amberg et al. (3) have already reported a pre-rRNA process-
ing defect for RAT1. The 5.8S rRNA was found to suffer a
processing and maturation defect, such that slightly longer
forms of this rRNA were produced at the nonpermissive
temperature. The exoribonuclease activity ascribed to p116
may be in part responsible for trimming the 5' ends of the
5.8S rRNA molecules, as suggested by these authors. It was
previously suggested that the enzymatic properties of p175
make it a good candidate for 5' trimming reactions in rRNA
maturation (25, 41). Additionally, it was found that frag-
ments of the internal transcribed spacer 1 of pre-rRNA
accumulate in yeast cells lacking p175 (39). This suggests a
role for the latter enzyme as a scavenger RNase in pre-rRNA
processing. It is plausible that p116 is involved in rRNA
processing, both as a trimming and as a scavenger RNase
which is somehow coupled to translocation across the nu-
clear envelope. Further investigation is necessary to un-
cover the interplay between all these seemingly diverse
activities and to begin to better understand the temporal and
spatial order of events involved in nuclear cytoplasmic RNA
trafficking and the relationship among transcription, process-
ing events, and trafficking. Additional study of the reaction
specificity of p116 is currently under way.
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